• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mutations of the phenylalanine hydroxylase gene in Iranian patients with phenylketonuria.伊朗苯丙酮尿症患者苯丙氨酸羟化酶基因的突变
Springerplus. 2015 Sep 23;4:542. doi: 10.1186/s40064-015-1309-8. eCollection 2015.
2
Mutation analysis of PAH gene in patients with PKU in western Iran and its association with polymorphisms: identification of four novel mutations.伊朗西部苯丙酮尿症患者苯丙氨酸羟化酶(PAH)基因突变分析及其与多态性的关联:鉴定出四个新突变
Metab Brain Dis. 2014 Mar;29(1):131-8. doi: 10.1007/s11011-013-9432-0. Epub 2013 Sep 19.
3
Spectrum of PAH gene mutations in 1547 phenylketonuria patients from Iran: a comprehensive systematic review.伊朗 1547 例苯丙酮尿症患者的 PAH 基因突变谱:一项全面的系统评价。
Metab Brain Dis. 2021 Jun;36(5):767-780. doi: 10.1007/s11011-021-00698-4. Epub 2021 Feb 24.
4
Mutation spectrum of phenylketonuria in Iranian population.伊朗人群苯丙酮尿症的突变谱。
Mol Genet Metab. 2011 Jan;102(1):29-32. doi: 10.1016/j.ymgme.2010.09.001. Epub 2010 Sep 16.
5
A comprehensive study of phenylalanine hydroxylase gene mutations in the Iranian phenylketonuria patients.对伊朗苯丙酮尿症患者苯丙氨酸羟化酶基因突变的综合研究。
Eur J Med Genet. 2019 Sep;62(9):103559. doi: 10.1016/j.ejmg.2018.10.011. Epub 2018 Oct 30.
6
Molecular analysis of exons 6 and 7 of phenylalanine hydroxylase gene mutations in Phenylketonuria patients in Western Iran.伊朗西部苯丙酮尿症患者苯丙氨酸羟化酶基因突变的外显子6和7的分子分析
Indian J Hum Genet. 2012 Sep;18(3):290-3. doi: 10.4103/0971-6866.107978.
7
Mutations of the phenylalanine hydroxylase gene in Iranian Azeri Turkish patients with phenylketonuria.伊朗阿塞拜疆土耳其族苯丙酮尿症患者苯丙氨酸羟化酶基因的突变
Genet Test Mol Biomarkers. 2010 Apr;14(2):233-5. doi: 10.1089/gtmb.2009.0153.
8
Mutation analysis of Phenylalanine hydroxylase gene in Iranian patients with Phenylketonuria.伊朗苯丙酮尿症患者苯丙氨酸羟化酶基因突变分析。
Med J Islam Repub Iran. 2018 Mar 11;32:21. doi: 10.14196/mjiri.32.21. eCollection 2018.
9
PREVALENCE OF PAH MUTATIONS IN GEORGIAN PKU PATIENTS COMPARED TO MOST FREQUENT PAH MUTATIONS IN EUROPEAN POPULATIONS.与欧洲人群中最常见的 PAH 突变相比,格鲁吉亚 PKU 患者的 PAH 突变的流行率。
Georgian Med News. 2020 Nov(308):143-149.
10
Mutation spectrum of the PAH gene in the PKU patients from Khorasan Razavi province of Iran.伊朗霍拉桑拉扎维省苯丙酮尿症患者 PAH 基因突变谱。
Gene. 2012 Sep 10;506(1):230-2. doi: 10.1016/j.gene.2012.06.043. Epub 2012 Jul 2.

引用本文的文献

1
Prevalence of common autosomal recessive and X-linked conditions in pregnant women in Vietnam: a cross-sectional study.越南孕妇常见常染色体隐性和X连锁疾病的患病率:一项横断面研究。
Sci Rep. 2025 May 30;15(1):19054. doi: 10.1038/s41598-025-03399-5.
2
Genetic Landscape and Clinical Features of Hyperphenylalaninemia in North Ossetia-Alania: High Frequency of P281L and P211T Genetic Variants in the Gene.北奥塞梯-阿兰尼亚高苯丙氨酸血症的遗传景观和临床特征:基因中 P281L 和 P211T 遗传变异的高频。
Int J Mol Sci. 2024 Apr 23;25(9):4598. doi: 10.3390/ijms25094598.
3
Mutational landscape of phenylketonuria in Iran.伊朗苯丙酮尿症的突变景观。
J Cell Mol Med. 2023 Sep;27(17):2457-2466. doi: 10.1111/jcmm.17865. Epub 2023 Jul 31.
4
Detection of Single-Nucleotide and Copy Number Defects Underlying Hyperphenylalaninemia by Next-Generation Sequencing.通过下一代测序检测高苯丙氨酸血症潜在的单核苷酸和拷贝数缺陷
Biomedicines. 2023 Jul 4;11(7):1899. doi: 10.3390/biomedicines11071899.
5
Multiplex Snapshot minisequencing for the detection of common PAH gene mutations in Iranian patients with Phenylketonuria.多重瞬时串联测序法检测伊朗苯丙酮尿症患者常见 PAH 基因突变。
Iran Biomed J. 2023 Jan 1;27(1):46-57. doi: 10.52547/ibj.3856.
6
Spectrum of PAH gene mutations in 1547 phenylketonuria patients from Iran: a comprehensive systematic review.伊朗 1547 例苯丙酮尿症患者的 PAH 基因突变谱:一项全面的系统评价。
Metab Brain Dis. 2021 Jun;36(5):767-780. doi: 10.1007/s11011-021-00698-4. Epub 2021 Feb 24.
7
Protein Degradation and the Pathologic Basis of Phenylketonuria and Hereditary Tyrosinemia.蛋白质降解与苯丙酮尿症和遗传性酪氨酸血症的病理基础。
Int J Mol Sci. 2020 Jul 15;21(14):4996. doi: 10.3390/ijms21144996.
8
IDENTIFICATION OF MUTATIONS IN THE PAH GENE IN PKU PATIENTS IN THE STATE OF MATO GROSSO.马托格罗索州苯丙酮尿症患者苯丙氨酸羟化酶基因突变的鉴定
Rev Paul Pediatr. 2020 Feb 14;38:e2018351. doi: 10.1590/1984-0462/2020/38/2018351. eCollection 2020.
9
Molecular Analysis of PKU-Associated PAH Mutations: A Fast and Simple Genotyping Test.苯丙酮尿症相关苯丙氨酸羟化酶突变的分子分析:一种快速简便的基因分型检测方法
Methods Protoc. 2018 Aug 16;1(3):30. doi: 10.3390/mps1030030.
10
Genotypes of 2579 patients with phenylketonuria reveal a high rate of BH4 non-responders in Russia.2579 例苯丙酮尿症患者的基因型显示俄罗斯存在较高比例的 BH4 无应答者。
PLoS One. 2019 Jan 22;14(1):e0211048. doi: 10.1371/journal.pone.0211048. eCollection 2019.

本文引用的文献

1
Molecular epidemiology and genotype-phenotype correlation in phenylketonuria patients from South Spain.西班牙南部苯丙酮尿症患者的分子流行病学和基因型-表型相关性。
J Hum Genet. 2013 May;58(5):279-84. doi: 10.1038/jhg.2013.16. Epub 2013 Mar 21.
2
Molecular epidemiology and BH4-responsiveness in patients with phenylalanine hydroxylase deficiency from Galicia region of Spain.西班牙加利西亚地区苯丙氨酸羟化酶缺乏症患者的分子流行病学和 BH4 反应性。
Gene. 2013 May 25;521(1):100-4. doi: 10.1016/j.gene.2013.03.004. Epub 2013 Mar 14.
3
Mutation spectrum of the PAH gene in the PKU patients from Khorasan Razavi province of Iran.伊朗霍拉桑拉扎维省苯丙酮尿症患者 PAH 基因突变谱。
Gene. 2012 Sep 10;506(1):230-2. doi: 10.1016/j.gene.2012.06.043. Epub 2012 Jul 2.
4
Phenylalanine hydroxylase deficiency: molecular epidemiology and predictable BH4-responsiveness in South Portugal PKU patients.苯丙氨酸羟化酶缺乏症:葡萄牙南部苯丙酮尿症患者的分子流行病学和可预测的 BH4 反应性。
Mol Genet Metab. 2011;104 Suppl:S86-92. doi: 10.1016/j.ymgme.2011.07.026. Epub 2011 Jul 31.
5
Mutation spectrum of phenylketonuria in Iranian population.伊朗人群苯丙酮尿症的突变谱。
Mol Genet Metab. 2011 Jan;102(1):29-32. doi: 10.1016/j.ymgme.2010.09.001. Epub 2010 Sep 16.
6
Mutations of the phenylalanine hydroxylase gene in Iranian Azeri Turkish patients with phenylketonuria.伊朗阿塞拜疆土耳其族苯丙酮尿症患者苯丙氨酸羟化酶基因的突变
Genet Test Mol Biomarkers. 2010 Apr;14(2):233-5. doi: 10.1089/gtmb.2009.0153.
7
Variations in genotype-phenotype correlations in phenylketonuria patients.苯丙酮尿症患者基因型-表型相关性的变异
Genet Mol Res. 2010 Jan 5;9(1):1-8. doi: 10.4238/vol9-1gmr670.
8
Phenylketonuria: an inborn error of phenylalanine metabolism.苯丙酮尿症:一种苯丙氨酸代谢的先天性疾病。
Clin Biochem Rev. 2008 Feb;29(1):31-41.
9
Neonatal screening in Europe; the situation in 2004.欧洲的新生儿筛查;2004年的情况。
J Inherit Metab Dis. 2007 Aug;30(4):430-8. doi: 10.1007/s10545-007-0644-5. Epub 2007 Jul 6.
10
Family conditions and dietary control in phenylketonuria.苯丙酮尿症的家庭状况与饮食控制
J Inherit Metab Dis. 2007 Oct;30(5):708-15. doi: 10.1007/s10545-007-0493-2. Epub 2007 Jun 14.

伊朗苯丙酮尿症患者苯丙氨酸羟化酶基因的突变

Mutations of the phenylalanine hydroxylase gene in Iranian patients with phenylketonuria.

作者信息

Biglari Alireza, Saffari Fatemeh, Rashvand Zahra, Alizadeh Safarali, Najafipour Reza, Sahmani Mehdi

机构信息

Department of Molecular Medicine and Genetics, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.

Department of Pediatrics, Qazvin University of Medical Sciences, Qazvin, Iran.

出版信息

Springerplus. 2015 Sep 23;4:542. doi: 10.1186/s40064-015-1309-8. eCollection 2015.

DOI:10.1186/s40064-015-1309-8
PMID:26413448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4579200/
Abstract

Phenylketonuria (PKU) is an autosomal recessive disease which results from mutations in the phenylalanine hydroxylase (PAH) gene. The aim of this study was the identification of sixteen different mutations in Iranian patients with hyperphenylalaninemia. The mutations were detected during the characterization of PAH genotypes of 39 PKU patients from Qazvin and Zanjan provinces of Iran. PAH mutations have been analyzed by PCR and direct sequencing of PCR products of the promoter region and all 13 exons of PAH gene, including the splicing sites. A mutation detection rate of 74.3 % was realized. Two mutations were found at high frequencies: R176X (10.25 %) and p.P281L (10.25 %). The frequencies of the other mutations were: IVS2+5G>A (2.56 %), IVS2+5G>C (2.56 %), p.L48S (2.56 %), p.R243Q (2.56 %), p.R252Q (5.12 %), p.R261Q (7.69 %), p.R261X (5.12 %), p.E280K (2.56 %), p.I283N (2.56 %), IVS9+5G>A (2.56 %), IVS9+1G>A (1.28 %), IVS11+1G>C (1.28 %), p.C357R (1.28 %), c.632delC (2.56 %). The present results confirm the high heterogeneity of the PAH locus and contribute to information about the distribution and frequency of PKU mutations in the Iranian population.

摘要

苯丙酮尿症(PKU)是一种常染色体隐性疾病,由苯丙氨酸羟化酶(PAH)基因突变所致。本研究旨在鉴定伊朗高苯丙氨酸血症患者中的16种不同突变。这些突变是在对来自伊朗加兹温省和赞詹省的39例PKU患者的PAH基因型进行特征分析过程中检测到的。通过PCR以及对PAH基因启动子区域和所有13个外显子(包括剪接位点)的PCR产物进行直接测序来分析PAH突变。突变检出率为74.3%。发现两种突变频率较高:R176X(10.25%)和p.P281L(10.25%)。其他突变的频率分别为:IVS2+5G>A(2.56%)、IVS2+5G>C(2.56%)、p.L48S(2.56%)、p.R243Q(2.56%)、p.R252Q(5.12%)、p.R261Q(7.69%)、p.R261X(5.12%)、p.E280K(2.56%)、p.I283N(2.56%)、IVS9+5G>A(2.56%)、IVS9+1G>A(1.28%)、IVS11+1G>C(1.28%)、p.C357R(1.28%)、c.632delC(2.56%)。目前的结果证实了PAH基因座的高度异质性,并为伊朗人群中PKU突变的分布和频率提供了信息。